A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices-Reference-Cited by-同舟云学术

A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices

Published:2003-05 Issue:2 Volume:139 Page:435-443
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Oka Michiko,Itoh Yoshinori,Wada Miyuki,Yamamoto Akira,Fujita Takuya

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0705246/fullpdf

Reference32 articles.

1. P/Q-type Ca2+ channel blocker ω-agatoxin IVA protects against brain injury after focal ischemia in rats;ASAKURA;Brain Res.,1997

2. Differential effect of gabapentin on neuronal and muscle calcium currents;ALDEN;J. Pharmacol. Exp. Ther.,2001

3. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial;BACKONJA;JAMA,1998

4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding;BRADFORD;Anal. Biochem.,1976

5. A selective N-type Ca2+-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia;BUCHAN;J. Cerebr. Blood Flow Metab.,1994

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Gabapentin-Fluoxetine Derivative GBP1F in a Murine Model of Depression, Anxiety and Cognition;Drug Design, Development and Therapy;2023-06

2. Gabapentin—Friend or foe?;Pain Practice;2022-10-27

3. Does gabapentin affect neural tube development? experimental study using an early stage chick embryo model;Turkish Neurosurgery;2021

4. Cardio-protective impact of gabapentin against doxorubicin-induced myocardial toxicity in rats; emphasis on modulation of inflammatory-apoptotic signaling;International Immunopharmacology;2021-01

5. Pharmacological options for the treatment of chronic migraine pain;Best Practice & Research Clinical Anaesthesiology;2020-09